The FDA folded a global standard into US device manufacturing law

The picture

On 2 February 2026, the FDA's Quality Management System Regulation (QMSR) took effect, amending 21 CFR Part 820 and incorporating by reference ISO 13485:2016, Medical devices — Quality management systems — Requirements for regulatory purposes. The rule was published two years earlier, on 2 February 2024, in the Federal Register's final rule (89 FR 7496, Docket FDA-2021-N-0507), giving manufacturers a two-year runway before enforcement began. The QMSR applies to finished device manufacturers who intend to commercially distribute medical devices in the United States, replacing FDA's prior inspection technique with a compliance program aligned to the incorporated standard.

What the documents show

FDA's page states the regulation harmonizes US manufacturing practice with ISO 13485:2016 rather than duplicating it. A detail the regulation page omits, but the Federal Register rule supplies: commenters asked whether the legacy terms device master record, design history file and device history record survive the change. FDA's response states it eliminated this terminology because none of the three appear in ISO 13485, and that content once filed under a device master record now sits in the manufacturer's medical device file, per the standard's Clause 4.2.3. FDA calls the recordkeeping burden "substantively similar," not identical — the familiar term has been retired even where the obligation persists.

What it is allowed to decide

This is a regulation about documentation practice, not a ruling on any single image or prototype. The sources support one class-6 claim: where a medical device file exists, it must be traceable and reproducible, a documented Auditability requirement. Neither text establishes Photometric or Optical authority for any visualization; nothing here says a rendered or prototyped view is dimensionally or optically faithful. Neither source states that every previs, prototype or marketing render used during development automatically becomes part of the medical device file; that depends on whether the manufacturer's own quality system designates it a controlled record.

The disclosure label

A visualization retained inside a compliant medical device file could carry a label stating: this record falls under the FDA's Quality Management System Regulation, incorporating ISO 13485:2016 as of 16 September 2026; it holds Auditability because it is version-controlled and traceable; it does not hold Photometric or Optical authority absent separate certification against fixture or lens data. A manufacturer's regulatory affairs function would plausibly assert this label.

• Is the image or model actually filed inside the manufacturer's medical device file, or is it a separate marketing asset outside the QMS boundary?
• Which ISO 13485 clause governs the record, and does it require the record to be reproducible years later?
• Has internal documentation dropped the retired device-history terminology, or does old language still create ambiguity about what is compliant?

The QMSR sets a documentation floor, not a verdict on any picture's fidelity. The durable lesson is that legal terminology changes even when obligations do not, and a compliance claim is only as strong as its citation to the current clause.